# Y. Neuzillet

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/y-neuzillet/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,516 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 43 |
| i10-index | 134 |
| Last Known Institution | Université de Versailles Saint-Quentin-en-Yvelines |
| OpenAlex ID | https://openalex.org/A5016602967 |
| ORCID iD | 0000-0003-4345-3598 |
| Works | 453 |

## Researcher papers

- [European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines](https://scholariq.org/papers/european-association-of-urology-guidelines-on-muscle-invasive-and-metastatic/)
- [Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer](https://scholariq.org/papers/updated-2016-eau-guidelines-on-muscle-invasive-and-metastatic-bladder-cancer/)
- [European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines](https://scholariq.org/papers/european-association-of-urology-guidelines-on-muscle-invasive-and-metastatic-2/)
- [EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype](https://scholariq.org/papers/egfr-as-a-potential-therapeutic-target-for-a-subset-of-muscle-invasive-bladder/)
- [Accuracy and Clinical Role of Fine Needle Percutaneous Biopsy With Computerized Tomography Guidance of Small (Less Than 4.0 Cm) Renal Masses](https://scholariq.org/papers/accuracy-and-clinical-role-of-fine-needle-percutaneous-biopsy-with-computerized/)
- [The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma](https://scholariq.org/papers/the-2021-updated-european-association-of-urology-guidelines-on-metastatic/)
- [A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies](https://scholariq.org/papers/a-16-gene-assay-to-predict-recurrence-after-surgery-in-localised-renal-cell/)
- [Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old](https://scholariq.org/papers/clinicopathological-characteristics-of-urothelial-bladder-cancer-in-patients/)
- [Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes](https://scholariq.org/papers/independent-component-analysis-uncovers-the-landscape-of-the-bladder-tumor/)
- [EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†](https://scholariq.org/papers/eau-esmo-consensus-statements-on-the-management-of-advanced-and-variant-bladder/)
- [French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes](https://scholariq.org/papers/french-recommendations-from-the-afu-cancer-committee-for-prostate-cancer-2025/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Researcher university

- [Université de Versailles Saint-Quentin-en-Yvelines](https://scholariq.org/institutions/universite-de-versailles-saint-quentin-en-yvelines/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.